Navigation Links
DNA Fingerprinting Could ID Viable Embryos
Date:5/14/2008

Finding may lead to improved pregnancy rates for in vitro patients, fewer multiple pregnancies

TUESDAY, May 13 (HealthDay News) -- Researchers say DNA tests may be able to tell doctors which embryos tabbed for in vitro fertilization (IVF) are most likely to result in the births of healthy babies.

The technique, discussed in a report published online May 14 in Human Reproduction, could also help fertility experts prevent accidental multiple pregnancies in their IVF patients.

A woman's eggs are fertilized with sperm during IVF and then allowed to develop in the laboratory for about five days until they reach the blastocyst, or very early embryo, stage. Doctors then decide which blastocysts look most likely to develop successfully and how many to put into the woman's womb.

Since reliable tests for determining which blastocysts are viable do not exist, couples often choose to have more than one blastocyst implanted in the woman's womb. While this increases the chances of a successful pregnancy, it also raises the risk of a woman becoming pregnant with two or more babies at once. Multiple pregnancies bring added dangers to the mother and babies.

In the study, researchers removed cells from the blastocysts being developed for 48 women, 25 of whom later became pregnant from the fertilized eggs resulting in 37 babies being born. The DNA from these cells was matched with the babies' DNA, thereby telling researchers which blastocysts developed into babies.

In analyzing the expression of genes in the viable and non-viable blastocysts, the team noted differing patterns. The genes expressed in the viable blastocysts, for example, are involved in cell adhesion, cell communication, cellular metabolic processes and response to stimuli -- all key processes involved in embryo implantation.

This finding could lead to doctors being able to select the single most viable embryo from a group for transfer from the laboratory to the womb, the researchers said.

"One of the major stumbling blocks to worldwide acceptance of a single embryo transfer policy is the lack of highly predictive criteria to select the single most viable embryo within a cohort," co-author Dr. Gayle Jones, senior research scientist at the Monash Immunology and Stem Cell Laboratories, said in a prepared statement. "The ability to use objective, measurable criteria rather than subjective observations, such as morphology, should improve the predictive value and provide sufficient confidence for clinicians to shift towards single embryo transfers for all patients without a concomitant drop in pregnancy rates. This would effectively reduce multiple pregnancies, which is a priority in the field of assisted reproductive medicine at present."

More work needs to be undertaken before these findings become applicable in the clinic, the researchers said.

More information

The American Society for Reproductive Medicine has more about infertility.



-- Kevin McKeever



SOURCE: European Society for Human Reproduction and Embryology, news release, May 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapists Warn Congress
2. Noise in Artery Could Warn of Heart Risk
3. Computer games high score could earn the Nobel Prize in medicine
4. Telemedicine could eradicate many expensive ED visits
5. Common Medications Could Cause Physical Impairment in the Elderly
6. New Lewin Group Analysis: Medicare Cuts for Nursing Facility Care Could Have Economic Impact Up to $4.2 Billion, Threaten Jobs
7. New treatment could reduce chronic lung disease in premature babies
8. Crime Scene Investigation methods could help in the battle against hospital infections
9. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
10. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
11. Readily available treatment could help prevent heart disease in kidney patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: